Elekta's latest generation intracranial radiosurgery system, Leksell Gamma Knife Icon, will be in the spotlight at the 2015 meeting of the Congress of Neurological Surgeons (CNS), September 26-30 in New Orleans, Louisiana.

Chosen by CNS to be highlighted as a key product in its Innovations Showcase, Icon features integrated stereotactic CT imaging, online Adaptive DoseControl, ultra-precise dose delivery and the availability of frameless treatments.

Icon is the only technology with Microradiosurgery capabilities allowing for the treatment of virtually any target the brain with ultra-high precision.

Leksell Gamma Knife Icon received U.S. Food and Drug Administration 510(k) clearance in July, enabling U.S. health care providers to offer this advanced technology to their patients.

"Icon represents another dramatic evolution of Gamma Knife technology," says Bill Yaeger, Elekta’s Executive Vice President, Region North America. "This system offers physicians a new way to deliver precise radiosurgery for a comprehensive range of cranial indications. Clinicians can choose either frame-based or frameless techniques to immobilize the patient’s head, and can opt for one or multiple treatment sessions.

"The motion management and imaging technologies in Icon raise the level of accuracy possible to the next level, enabling ultra-precise Microradiosurgery in cases that require extreme precision."

In July, doctors at University Hospital La Timone (Marseille, France) were first in the world to use their Gamma Knife Icon system to treat patients. To date, the hospital has treated 79 patients with Icon, several of whom benefited from the unique, highly precise cone beam CT (CBCT) stereotactic imaging and motion management technologies in frameless therapy deliveries.

"Different generations of Gamma Knife technology are operating in over 300 centers worldwide, amassing treatments of more than 900,000 patients since 1991. Hospital La Timone itself has treated over 15,000 patients," Yaeger adds. "Globally, Gamma Knife radiosurgery is recognized as the gold standard treatment for intracranial pathologies."

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders.

The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care.